Two human hepatoma cell lines, HepG2 and Hep3B cells, differ primarily in their p53 status, with HepG2 expressing wild-type p53 and Hep3B lacking p53, making them valuable models for studying p53-related mechanisms in HBV research [28,31,32]. Here, TP53 is linked to hepatocellular carcinoma.